The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Point of Care & Rapid Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The global Point of Care & Rapid Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care & Rapid Diagnostics in various end use industries. The expanding demands from the Hospital and Home Care, are propelling Point of Care & Rapid Diagnostics market. Rapid Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care & Rapid Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care & Rapid Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care & Rapid Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care & Rapid Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care & Rapid Diagnostics covered in this report include Johnson and Johnson, Thermo Fisher Scientific, Bio-Techne, Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, BD and Sysmex, etc.
The global Point of Care & Rapid Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioMérieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Global Point of Care & Rapid Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care & Rapid Diagnostics market, Segment by Type:
Rapid Test
Molecular Diagnostics
Global Point of Care & Rapid Diagnostics market, by Application
Hospital
Home Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care & Rapid Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Point of Care & Rapid Diagnostics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Point of Care & Rapid Diagnostics in various end use industries. The expanding demands from the Hospital and Home Care, are propelling Point of Care & Rapid Diagnostics market. Rapid Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Molecular Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point of Care & Rapid Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point of Care & Rapid Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point of Care & Rapid Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point of Care & Rapid Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point of Care & Rapid Diagnostics covered in this report include Johnson and Johnson, Thermo Fisher Scientific, Bio-Techne, Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, BD and Sysmex, etc.
The global Point of Care & Rapid Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson and Johnson
Thermo Fisher Scientific
Bio-Techne
Roche Diagnostics
Siemens Healthineers
Abbott Laboratories
Danaher Corporation
BD
Sysmex
Cardinal Health
Quidel
GE Healthcare
EKF Diagnostics
bioMérieux SA
Accubiotech
PTS Diagnostics
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Global Point of Care & Rapid Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point of Care & Rapid Diagnostics market, Segment by Type:
Rapid Test
Molecular Diagnostics
Global Point of Care & Rapid Diagnostics market, by Application
Hospital
Home Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point of Care & Rapid Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Point of Care & Rapid Diagnostics
1.1 Point of Care & Rapid Diagnostics Market Overview
1.1.1 Point of Care & Rapid Diagnostics Product Scope
1.1.2 Point of Care & Rapid Diagnostics Market Status and Outlook
1.2 Global Point of Care & Rapid Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point of Care & Rapid Diagnostics Market Size by Region (2018-2029)
1.4 Global Point of Care & Rapid Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Point of Care & Rapid Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point of Care & Rapid Diagnostics Market Size (2018-2029)
1.6.1 North America Point of Care & Rapid Diagnostics Market Size (2018-2029)
1.6.2 Europe Point of Care & Rapid Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size (2018-2029)
1.6.4 Latin America Point of Care & Rapid Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Point of Care & Rapid Diagnostics Market Size (2018-2029)
2 Point of Care & Rapid Diagnostics Market by Type
2.1 Introduction
2.1.1 Rapid Test
2.1.2 Molecular Diagnostics
2.2 Global Point of Care & Rapid Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point of Care & Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point of Care & Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point of Care & Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point of Care & Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point of Care & Rapid Diagnostics Revenue Breakdown by Type (2018-2029)
3 Point of Care & Rapid Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Home Care
3.2 Global Point of Care & Rapid Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point of Care & Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point of Care & Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point of Care & Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point of Care & Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point of Care & Rapid Diagnostics Revenue Breakdown by Application (2018-2029)
4 Point of Care & Rapid Diagnostics Competition Analysis by Players
4.1 Global Point of Care & Rapid Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point of Care & Rapid Diagnostics as of 2022)
4.3 Date of Key Players Enter into Point of Care & Rapid Diagnostics Market
4.4 Global Top Players Point of Care & Rapid Diagnostics Headquarters and Area Served
4.5 Key Players Point of Care & Rapid Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Point of Care & Rapid Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson and Johnson
5.1.1 Johnson and Johnson Profile
5.1.2 Johnson and Johnson Main Business
5.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Products, Services and Solutions
5.1.4 Johnson and Johnson Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson and Johnson Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Bio-Techne
5.3.1 Bio-Techne Profile
5.3.2 Bio-Techne Main Business
5.3.3 Bio-Techne Point of Care & Rapid Diagnostics Products, Services and Solutions
5.3.4 Bio-Techne Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Diagnostics Recent Developments
5.4 Roche Diagnostics
5.4.1 Roche Diagnostics Profile
5.4.2 Roche Diagnostics Main Business
5.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Products, Services and Solutions
5.4.4 Roche Diagnostics Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Diagnostics Recent Developments
5.5 Siemens Healthineers
5.5.1 Siemens Healthineers Profile
5.5.2 Siemens Healthineers Main Business
5.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Products, Services and Solutions
5.5.4 Siemens Healthineers Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Siemens Healthineers Recent Developments
5.6 Abbott Laboratories
5.6.1 Abbott Laboratories Profile
5.6.2 Abbott Laboratories Main Business
5.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Products, Services and Solutions
5.6.4 Abbott Laboratories Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Laboratories Recent Developments
5.7 Danaher Corporation
5.7.1 Danaher Corporation Profile
5.7.2 Danaher Corporation Main Business
5.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Products, Services and Solutions
5.7.4 Danaher Corporation Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Danaher Corporation Recent Developments
5.8 BD
5.8.1 BD Profile
5.8.2 BD Main Business
5.8.3 BD Point of Care & Rapid Diagnostics Products, Services and Solutions
5.8.4 BD Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 BD Recent Developments
5.9 Sysmex
5.9.1 Sysmex Profile
5.9.2 Sysmex Main Business
5.9.3 Sysmex Point of Care & Rapid Diagnostics Products, Services and Solutions
5.9.4 Sysmex Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Sysmex Recent Developments
5.10 Cardinal Health
5.10.1 Cardinal Health Profile
5.10.2 Cardinal Health Main Business
5.10.3 Cardinal Health Point of Care & Rapid Diagnostics Products, Services and Solutions
5.10.4 Cardinal Health Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Cardinal Health Recent Developments
5.11 Quidel
5.11.1 Quidel Profile
5.11.2 Quidel Main Business
5.11.3 Quidel Point of Care & Rapid Diagnostics Products, Services and Solutions
5.11.4 Quidel Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Quidel Recent Developments
5.12 GE Healthcare
5.12.1 GE Healthcare Profile
5.12.2 GE Healthcare Main Business
5.12.3 GE Healthcare Point of Care & Rapid Diagnostics Products, Services and Solutions
5.12.4 GE Healthcare Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 GE Healthcare Recent Developments
5.13 EKF Diagnostics
5.13.1 EKF Diagnostics Profile
5.13.2 EKF Diagnostics Main Business
5.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Products, Services and Solutions
5.13.4 EKF Diagnostics Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 EKF Diagnostics Recent Developments
5.14 bioMérieux SA
5.14.1 bioMérieux SA Profile
5.14.2 bioMérieux SA Main Business
5.14.3 bioMérieux SA Point of Care & Rapid Diagnostics Products, Services and Solutions
5.14.4 bioMérieux SA Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 bioMérieux SA Recent Developments
5.15 Accubiotech
5.15.1 Accubiotech Profile
5.15.2 Accubiotech Main Business
5.15.3 Accubiotech Point of Care & Rapid Diagnostics Products, Services and Solutions
5.15.4 Accubiotech Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Accubiotech Recent Developments
5.16 PTS Diagnostics
5.16.1 PTS Diagnostics Profile
5.16.2 PTS Diagnostics Main Business
5.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Products, Services and Solutions
5.16.4 PTS Diagnostics Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 PTS Diagnostics Recent Developments
5.17 Chembio Diagnostics
5.17.1 Chembio Diagnostics Profile
5.17.2 Chembio Diagnostics Main Business
5.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Products, Services and Solutions
5.17.4 Chembio Diagnostics Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.17.5 Chembio Diagnostics Recent Developments
5.18 Trinity Biotech
5.18.1 Trinity Biotech Profile
5.18.2 Trinity Biotech Main Business
5.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Products, Services and Solutions
5.18.4 Trinity Biotech Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.18.5 Trinity Biotech Recent Developments
5.19 Sekisui Diagnostics
5.19.1 Sekisui Diagnostics Profile
5.19.2 Sekisui Diagnostics Main Business
5.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Products, Services and Solutions
5.19.4 Sekisui Diagnostics Point of Care & Rapid Diagnostics Revenue (US$ Million) & (2018-2023)
5.19.5 Sekisui Diagnostics Recent Developments
6 North America
6.1 North America Point of Care & Rapid Diagnostics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point of Care & Rapid Diagnostics Market Dynamics
11.1 Point of Care & Rapid Diagnostics Industry Trends
11.2 Point of Care & Rapid Diagnostics Market Drivers
11.3 Point of Care & Rapid Diagnostics Market Challenges
11.4 Point of Care & Rapid Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
